Michal Abrahamowicz

Research Scientist, PhD

 

Appointments

  • James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
  • Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre 

Research Interests

  • Biostatistics
  • Survival analysis
  • Pharmacoepidemiology
  • Clinical epidemiology
  • Epidemiologic methods
  • Longitudinal analysis
  • Non-communicable disease epidemiology

Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.

Learn more

His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).

Recent News Coverage

Arthritis Research Funding Highlights

Arthritis Research Funding Highlights Dr. Cheryl Barnabe (Arthritis Research Canada, Alberta) is Canada’s leader in research relating to the health of the indigenous community. Dr. Barnabe as Co-Principal Investigator with Cara Bablitz, Lynden Crowshoe, Michael Green,...

Arthritis Research Canada responding to the COVID-19

Arthritis Research Canada responding to the COVID-19 March 16, 2020 (Vancouver, BC) –In light of the recent developments with the COVID-19 outbreak and the changing recommendations from the governments of BC and Canada, Arthritis Research Canada is carefully...